These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12066972)

  • 1. Levofloxacin-induced toxic epidermal necrolysis in an elderly patient.
    Digwood-Lettieri S; Reilly KJ; Haith LR; Patton ML; Guilday RJ; Cawley MJ; Ackerman BH
    Pharmacotherapy; 2002 Jun; 22(6):789-93. PubMed ID: 12066972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin: a probable cause of toxic epidermal necrolysis.
    Melde SL
    Ann Pharmacother; 2001 Nov; 35(11):1388-90. PubMed ID: 11724089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New generations of quinolones: with particular attention to levofloxacin.
    Ambrose PG; Owens RC; Quintiliani R; Nightingale CH
    Conn Med; 1997 May; 61(5):269-72. PubMed ID: 9197076
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized seizure and toxic epidermal necrolysis following levofloxacin exposure.
    Christie MJ; Wong K; Ting RH; Tam PY; Sikaneta TG
    Ann Pharmacother; 2005 May; 39(5):953-5. PubMed ID: 15827068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case Report of Toxic Epidermal Necrolysis Due to Ofloxacin.
    Vaghela JJ; Nimbark VN; Chavda BC; Mehta HH; Purohit BM
    Curr Drug Saf; 2018; 13(2):137-140. PubMed ID: 29506464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin-associated Achilles tendon rupture and tendinopathy.
    Melhus A; Apelqvist J; Larsson J; Eneroth M
    Scand J Infect Dis; 2003; 35(10):768-70. PubMed ID: 14606622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin revisited.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):55. PubMed ID: 21738109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Achilles pain and functional impotence in a patient with chronic obstructive pulmonary disease with pneumonia. Tendon rupture caused by levofloxacin].
    Nuño Mateo FJ; Noval Menéndez J; Suárez M; Guinea O
    Rev Clin Esp; 2001 Sep; 201(9):539-40. PubMed ID: 11692412
    [No Abstract]   [Full Text] [Related]  

  • 9. Lamotrigine-induced toxic epidermal necrolysis in three patients treated for bipolar disorder.
    Varghese SP; Haith LR; Patton ML; Guilday RE; Ackerman BH
    Pharmacotherapy; 2006 May; 26(5):699-704. PubMed ID: 16718941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leave the levofloxacin? A case report of levofloxacin-induced psychosis.
    Steuber H; Williams D; Rech MA
    Am J Emerg Med; 2018 Aug; 36(8):1528.e1-1528.e2. PubMed ID: 29779676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levofloxacin-induced bilateral Achilles tendonitis.
    Lewis JR; Gums JG; Dickensheets DL
    Ann Pharmacother; 1999; 33(7-8):792-5. PubMed ID: 10466906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe pneumonia caused by combined infection with Pneumocystis jiroveci, parainfluenza virus type 3, cytomegalovirus, and Aspergillus fumigatus in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Lee T; Bae YJ; Park SK; Park HJ; Kim SH; Cho YS; Moon HB; Lee SO; Kim TB
    Acta Derm Venereol; 2010 Nov; 90(6):625-9. PubMed ID: 21057748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease.
    Karim A; Ahmed S; Rossoff LJ; Siddiqui RK; Steinberg HN
    Clin Infect Dis; 2001 Dec; 33(12):2088-90. PubMed ID: 11712098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactoid reaction to levofloxacin.
    Smythe MA; Cappelletty DM
    Pharmacotherapy; 2000 Dec; 20(12):1520-3. PubMed ID: 11130225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Teo WL; Pang SM
    Ann Acad Med Singap; 2010 Aug; 39(8):660-1. PubMed ID: 20838711
    [No Abstract]   [Full Text] [Related]  

  • 16. [Update on the role of levofloxacin in the management of acute community-acquired pneumonia].
    Bru JP
    Presse Med; 2002 Jun; 31(21 Pt 2):S19-22. PubMed ID: 12148386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of length of stay, total costs, and treatment success between intravenous moxifloxacin 400 mg and levofloxacin 750 mg among hospitalized patients with community-acquired pneumonia.
    Friedman H; Song X; Crespi S; Navaratnam P
    Value Health; 2009; 12(8):1135-43. PubMed ID: 19695010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral levofloxacin in the treatment of community-acquired pneumonia.
    Nicodemo AC; Lima Nicodemo E; Idrahim KY
    Braz J Infect Dis; 2000 Apr; 4(2):61-6. PubMed ID: 10795070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levofloxacin. expediency of high-dose regimens in therapy of lower respiratory tract infections].
    Guchev IA; Melekhina EV; Iudenich OV
    Antibiot Khimioter; 2011; 56(3-4):17-31. PubMed ID: 21913405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.